An Ethanol/Sodium Citrate Locking Solution Compared to Heparin to Prevent Hemodialysis Catheter-Related Infections: a Randomized Pilot Study

Canadian Institute for Health Information. Canadian Organ Replacement Register Annual Report: Treatment of End-Stage Organ Failure in Canada, 2003 to 2012. Ottawa, ON: CIHI 2014 Available on: https://secure.cihi.ca/free_products/2014_CORR_Annual_Report_EN.pdf. Accessed October 7, 2015.

Pisoni RL Zepel L Port FK Robinson BM Trends in US Vascular Access Use, Patient Preferences, and Related Practices: An Update From the US DOPPS Practice Monitor With International Comparisons. Am J Kidney Dis 2015;65(6):905–915

Lee T Barker J Allon M Tunneled catheters in hemodialysis patients: reasons and subsequent outcomes. Am J Kidney Dis 2005;46(3):501–508

Lok CE Mokrzycki MH Prevention and management of catheter-related infection in hemodialysis patients. Kidney Int 2011;79(6):587–598

Lok CE Stanley KE Hux JE Richardson R Tobe SW Conly J Hemodialysis infection prevention with polysporin ointment. J Am Soc Nephrol 2003;14(1):169–179

Weijmer MC van den Dorpel MA Van de Ven PJ et al; CITRATE Study Group. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol 2005;16(9):2769–2777

Weijmer MC Vervloet MG ter Wee PM Compared to tunnelled cuffed haemodialysis catheters, temporary untunnelled catheters are associated with more complications already within 2 weeks of use. Nephrol Dial Transplant 2004;19(3):670–677

Thomson PC Stirling CM Geddes CC Morris ST Mactier RA Vascular access in haemodialysis patients: a modifiable risk factor for bacteraemia and death. QJM 2007;100(7):415–422

Jaffer Y Selby NM Taal MW Fluck RJ McIntyre CW A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection. Am J Kidney Dis 2008;51(2):233–241

James MT Conley J Tonelli M Manns BJ MacRae J Hemmelgarn BR Alberta Kidney Disease Network. Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections. Ann Intern Med 2008;148(8):596–605

Labriola L Crott R Jadoul M Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials. Nephrol Dial Transplant 2008;23(5):1666–1672

Rabindranath KS Bansal T Adams J et al. Systematic review of antimicrobials for the prevention of haemodialysis catheter-related infections. Nephrol Dial Transplant 2009;24(12):3763–3774

Snaterse M Rüger W Scholte Op Reimer WJ Lucas C Antibiotic-based catheter lock solutions for prevention of catheter-related bloodstream infection: a systematic review of randomised controlled trials. J Hosp Infect 2010;75(1):1–11

Yahav D Rozen-Zvi B Gafter-Gvili A Leibovici L Gafter U Paul M Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis 2008;47(1):83–93

Johnson DW MacGinley R Kay TD et al. A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters. Nephrol Dial Transplant 2002;17(10):1802–1807

Johnson DW van Eps C Mudge DW et al. Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus mupirocin for the prevention of catheter-associated infections in hemodialysis patients. J Am Soc Nephrol 2005;16(5):1456–1462

Levin A Mason AJ Jindal KK Fong IW Goldstein MB Prevention of hemodialysis subclavian vein catheter infections by topical povidone-iodine. Kidney Int 1991;40(5):934–938

Sesso R Barbosa D Leme IL et al. Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: effect of mupirocin ointment. J Am Soc Nephrol 1998;9(6):1085–1092

Trerotola SO Johnson MS Shah H et al. Tunneled hemodialysis catheters: use of a silver-coated catheter for prevention of infection—a randomized study. Radiology 1998;207(2):491–496

Ishizuka M Nagata H Takagi K Kubota K Comparison of 0.05% chlorhexidine and 10% povidone-iodine as cutaneous disinfectant for prevention of central venous catheter-related bloodstream infection: a comparative study. Eur Surg Res 2009;43(3):286–290

McCann M Moore ZE Interventions for preventing infectious complications in haemodialysis patients with central venous catheters. Cochrane Database Syst Rev 20101:CD006894

Bloom BS Fendrick AM Chernew ME Patel P Clinical and economic effects of mupirocin calcium on preventing Staphylococcus aureus infection in hemodialysis patients: a decision analysis. Am J Kidney Dis 1996;27(5):687–694

Boelaert JR De Smedt RA De Baere YA et al. The influence of calcium mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in haemodialysis patients. Nephrol Dial Transplant 1989;4(4):278–281

Kluytmans JA Manders MJ van Bommel E Verbrugh H Elimination of nasal carriage of Staphylococcus aureus in hemodialysis patients. Infect Control Hosp Epidemiol 1996;17(12):793–797

Tacconelli E Carmeli Y Aizer A Ferreira G Foreman MG D'Agata EM Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin Infect Dis 2003;37(12):1629–1638

Abbas SA Haloob IA Taylor SL et al. Effect of antimicrobial locks for tunneled hemodialysis catheters on bloodstream infection and bacterial resistance: a quality improvement report. Am J Kidney Dis 2009;53(3):492–502

Landry DL Braden GL Gobeille SL Haessler SD Vaidya CK Sweet SJ Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis. Clin J Am Soc Nephrol 2010;5(10):1799–1804

Bell AL Gu X Burczynski FJ Vercaigne LM Ethanol/trisodium citrate for hemodialysis catheter lock. Clin Nephrol 2004;62(5):369–373

Maharaj AR Zelenitsky SA Vercaigne LM Effect of an ethanol/trisodium citrate hemodialysis catheter locking solution on isolates of Candida albicans. Hemodial Int 2008;12(3):342–347

Takla TA Zelenitsky SA Vercaigne LM Effect of ethanol/trisodium citrate lock on microorganisms causing hemodialysis catheter-related infections. J Vasc Access8(4):262–267

Takla TA Zelenitsky SA Vercaigne LM Effectiveness of a 30% ethanol/4% trisodium citrate locking solution in preventing biofilm formation by organisms causing haemodialysis catheter-related infections. J Antimicrob Chemother 2008;62(5):1024–1026

Bell AL Jayaraman R Vercaigne LM Effect of ethanol/trisodium citrate lock on the mechanical properties of carbothane hemodialysis catheters. Clin Nephrol 2006;65(5):342–348

Landry DL Jaber RA Hanumanthappa N et al. Effects of prolonged ethanol lock exposure to carbothane- and silicone-based hemodialysis catheters: a 26-week study. J Vasc Access 2015;16(5):367–371

Vercaigne LM Takla TA Raghavan J Long-term effect of an ethanol/sodium citrate locking solution on the mechanical properties of hemodialysis catheters. J Vasc Access 2010;11(1):12–16

Woo LWJ Zibell M Gardner C Anderson W Long term polyurethane catheter alcohol compatibility I, physical and rheological studies. Available at: http://www.leconwoo.com/publications/Woo%20Polyurethane%20Catheter%20Alcohol%20Compatibility%20v2.pdf. Accessed: October 7, 2015.

Lee EC Whitehead AL Jacques RM Julious SA The statistical interpretation of pilot trials: should significance thresholds be reconsidered? BMC Med Res Methodol 2014;14(1):41

Centers for Disease Control and Prevention (CDC). Vital signs: central line-associated blood stream infections—United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep 2011;60(8):243–248

Daniels KR Frei CR The United States’ progress toward eliminating catheter-related bloodstream infections: incidence, mortality, and hospital length of stay from 1996 to 2008. Am J Infect Control 2013;41(2):118–121

Klevens RM Edwards JR Richards CL Jr et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 2007;122(2):160–166

Onder AM Billings AA Chandar J et al. Antibiotic lock solutions allow less systemic antibiotic exposure and less catheter malfunction without adversely affecting antimicrobial resistance patterns. Hemodial Int 2013;17(1):75–85

Broom JK Krishnasamy R Hawley CM Playford EG Johnson DW A randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients—the HEALTHY-CATH trial. BMC Nephrol 2012;13(1):146

Tan M Lau J Guglielmo BJ Ethanol locks in the prevention and treatment of catheter-related bloodstream infections. Ann Pharmacother 2014;48(5):607–615

Mermel LA Alang N Adverse effects associated with ethanol catheter lock solutions: a systematic review. J Antimicrob Chemother 2014;69(10):2611–2619

Oliveira C Nasr A Brindle M Wales PW Ethanol locks to prevent catheter-related bloodstream infections in parenteral nutrition: a meta-analysis. Pediatrics 2012;129(2):318–329

Rajpurkar M McGrath E Joyce J Boldt-MacDonald K Chitlur M Lusher J Therapeutic and prophylactic ethanol lock therapy in patients with bleeding disorders. Haemophilia 2014;20(1):52–57

Wolf J Shenep JL Clifford V Curtis N Flynn PM Ethanol lock therapy in pediatric hematology and oncology. Pediatr Blood Cancer 2013;60(1):18–25

Wong T Clifford V McCallum Z et al. Central venous catheter thrombosis associated with 70% ethanol locks in pediatric intestinal failure patients on home parenteral nutrition: a case series. JPEN J Parenter Enteral Nutr 2012;36(3):358–360

Heng AE Abdelkader MH Diaconita M Nony A Guerraoui A Caillot N Rince M Deteix P Souweine B Impact of short term use of interdialytic 60% ethanol lock solution on tunneled silicone catheter dysfunction. Clin Nephrol 2011 Jun75(6):534–541

Schilcher G Schlagenhauf A Schneditz D et al. Ethanol causes protein precipitation—new safety issues for catheter locking techniques. PLoS ONE 2013;8(12):e84869

Manns BJ Scott-Douglas N Tonelli M et al. An economic evaluation of rt-PA locking solution in dialysis catheters. J Am Soc Nephrol 2014;25(12):2887–2895